Investigation Overview
An investigation on behalf of investors, who currently hold shares of Juniper Pharmaceuticals, Inc. (NASDAQ: JNP), was announced concerning whether the takeover of Juniper Pharmaceuticals, Inc. by Catalent, Inc is unfair to NASDAQ: JNP stockholders. The investigation by a law firm concerns whether certain officers and directors of Juniper Pharmaceuticals, Inc. breached their fiduciar...
You must register (for free) or login to view the entire investigation.